Form 8-K · Current Report · Filed 2025-08-27
Cardinal Health Completes Public Offering of $1 Billion in Notes for Solaris Health Acquisition
On August 27, 2025, Cardinal Health, Inc. completed a public offering of $600,000,000 of 4.500% Notes due 2030 and $400,000,000 of 5.150% Notes due 2035. The net proceeds from the sale of these Notes will be used to fund a portion of the consideration payable in connection with the proposed acquisition of Solaris Health. If the acquisition is not consummated by August 12, 2026, or if the company decides not to pursue the acquisition, the company will redeem the Notes at 101% of the aggregate principal amount plus accrued interest.
- Filer
- Cardinal Health Inc. CAH · NYSE
- Filed
- Accession
- 0001193125-25-189845
- CIK
- 0000721371
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Creation of a Direct Financial Obligation
Market reaction
Close before filing
$147.49
Next session
+1.4%
Since filing
+56.0%
Latest close
$230.03
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CAH reporting the same item, with the next session's move:
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Never miss another CAH filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.